Summit Tx Capital, L.P. Astrazeneca PLC Transaction History
Summit Tx Capital, L.P.
- $2.42 Trillion
- Q3 2025
A detailed history of Summit Tx Capital, L.P. transactions in Astrazeneca PLC stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 49,621 shares of AZN stock, worth $4.44 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
49,621
Previous 7,662
547.62%
Holding current value
$4.44 Million
Previous $535 Million
611.01%
% of portfolio
0.16%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,501Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...